Quarterly ResultAug 10, 2026, 04:16 PM
National Health Investors Q2 EPS $1.15; Revenue $121.3M
AI Summary
National Health Investors reported strong second-quarter 2026 results with total revenues increasing by 33.8% to $121.3 million and diluted EPS rising 45.6% to $1.15. Net income attributable to common stockholders grew 50.5% to $55.6 million. For the first six months of 2026, revenues were up 31.4% to $236.4 million and diluted EPS increased 28.8% to $1.97. The company also completed the sale of 37 properties in July 2026, which were classified as assets held for sale at quarter-end.
Key Highlights
- Q2 2026 total revenues increased 33.8% to $121.3 million from $90.7 million year-over-year.
- Q2 2026 diluted earnings per share rose 45.6% to $1.15 from $0.79 year-over-year.
- Net income attributable to common stockholders for Q2 2026 was $55.6 million, up 50.5%.
- Net cash provided by operating activities for H1 2026 increased 11.4% to $118.4 million.
- Total assets stood at $2.96 billion as of June 30, 2026.
- Declared a dividend of $0.92 per share for Q2 2026.
- Completed the sale of 37 properties in July 2026, previously held for sale at $30.9 million.
Price Impact
More from NHI